In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract.
Buchheim-Schmidt S, Peters U, Duysburgh C, Van den Abbeele P, Marzorati M, Keller T, Martin D, Klement P, Baumgartner S.
Buchheim-Schmidt S, et al.
Z Gastroenterol. 2021 May;59(5):423-437. doi: 10.1055/a-1404-3344. Epub 2021 May 12.
Z Gastroenterol. 2021.
PMID: 33979845
Free PMC article.
Using the Okoubaka-adapted microbial community from SHIME, 48 h challenge tests were performed with enterotoxigenic Escherichia coli (ETEC) and Salmonella enteritidis in 4 different doses (10(3)-10(8) colony forming units as typical in vivo infectious doses). ...
Using the Okoubaka-adapted microbial community from SHIME, 48 h challenge tests were performed with enterotoxigenic Escherichia coli …